Ditchcarbon
  • Contact
  1. Organizations
  2. Cambrex Karlskoga
Public Profile
Pharmaceutical Preparation Manufacturing
SE
updated 10 days ago

Cambrex Karlskoga

Company website

Cambrex Karlskoga, a prominent subsidiary of Cambrex Corporation, is headquartered in Karlskoga, Sweden. Established in 1981, the company has become a key player in the pharmaceutical industry, specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. With a strong focus on quality and compliance, Cambrex Karlskoga has achieved significant milestones, including certifications from regulatory bodies such as the FDA and EMA. The company offers a range of services, including custom synthesis and process development, which are distinguished by their commitment to innovation and efficiency. Cambrex Karlskoga's strategic location in Sweden allows it to serve a diverse clientele across Europe and North America, solidifying its position as a trusted partner in the pharmaceutical supply chain. With a reputation for excellence, Cambrex Karlskoga continues to contribute to advancements in drug development and manufacturing.

DitchCarbon Score

How does Cambrex Karlskoga's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Cambrex Karlskoga's score of 41 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

62%

Let us know if this data was useful to you

Cambrex Karlskoga's reported carbon emissions

In 2023, Cambrex Karlskoga reported total carbon emissions of approximately 2,849,000 kg CO2e for Scope 1 and 2 combined, alongside about 53,330,000 kg CO2e for Scope 3 emissions. This marks a reduction from 2022, where Scope 1 and 2 emissions were about 2,607,000 kg CO2e and Scope 3 emissions were approximately 55,540,000 kg CO2e. Over the past few years, Cambrex has demonstrated a commitment to reducing its greenhouse gas emissions, with significant targets set for the near future. Cambrex aims to achieve a 52% reduction in absolute Scope 1 and 2 emissions by 2030, using 2018 as the baseline year. Additionally, the company has committed to a 42% reduction in Scope 3 emissions by 2030, with a baseline year of 2020. These targets are aligned with the Science Based Targets initiative (SBTi), which has classified them as consistent with the reductions necessary to limit global warming to 1.5°C. The emissions data and reduction targets are inherited from Cambrex Corporation, reflecting the company's broader corporate sustainability strategy. Cambrex Karlskoga's efforts are part of a comprehensive approach to address climate change and enhance sustainability within the pharmaceutical and biotechnology sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2017201820192020202120222023
Scope 1
-
-
-
-
-
-
-
Scope 2
-
-
-
-
-
-
-
Scope 3
-
-
-
00,000,000
00,000,000
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cambrex Karlskoga's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Cambrex Karlskoga is in SE, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Cambrex Karlskoga is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

K+S Aktiengesellschaft

DE
•
Chemical and fertilizer minerals, salt and other mining and quarrying products n.e.c.
Updated 1 day ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Samsung Biologics

KR
•
Pharmaceutical Preparation Manufacturing
Updated 20 days ago

Siegfried Holding

CH
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Wuxi Apptec

CN
•
Research and development services (73)
Updated 15 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy